These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
852 related items for PubMed ID: 17449991
1. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991 [Abstract] [Full Text] [Related]
2. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. J Pain Symptom Manage; 2006 Sep; 32(3):287-93. PubMed ID: 16939853 [Abstract] [Full Text] [Related]
3. Validation of a screener and opioid assessment measure for patients with chronic pain. Butler SF, Budman SH, Fernandez K, Jamison RN. Pain; 2004 Nov; 112(1-2):65-75. PubMed ID: 15494186 [Abstract] [Full Text] [Related]
4. Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study. Jamison RN, Link CL, Marceau LD. Pain Med; 2009 Sep; 10(6):1084-94. PubMed ID: 19671087 [Abstract] [Full Text] [Related]
5. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Moore TM, Jones T, Browder JH, Daffron S, Passik SD. Pain Med; 2009 Nov; 10(8):1426-33. PubMed ID: 20021601 [Abstract] [Full Text] [Related]
6. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, Palombi D, Jamison RN. J Pain Symptom Manage; 2004 Sep; 28(3):250-8. PubMed ID: 15336337 [Abstract] [Full Text] [Related]
7. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. J Pain; 2009 Feb; 10(2):131-46. PubMed ID: 19187890 [Abstract] [Full Text] [Related]
10. A comparison of various risk screening methods in predicting discharge from opioid treatment. Jones T, Moore T, Levy JL, Daffron S, Browder JH, Allen L, Passik SD. Clin J Pain; 2012 Feb; 28(2):93-100. PubMed ID: 21750461 [Abstract] [Full Text] [Related]
11. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pain Pract; 2008 Feb; 8(4):287-313. PubMed ID: 18503626 [Abstract] [Full Text] [Related]
12. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. Ives TJ, Chelminski PR, Hammett-Stabler CA, Malone RM, Perhac JS, Potisek NM, Shilliday BB, DeWalt DA, Pignone MP. BMC Health Serv Res; 2006 Apr 04; 6():46. PubMed ID: 16595013 [Abstract] [Full Text] [Related]
13. [Abuse of opioid therapy in somatoform pain disorder. A contribution from a psychosomatic/pain therapist point of view to the discussion of the indication of opioids in nonmalignant pain based on 8 cases]. Wambach S, Rohr P, Häuser W. Schmerz; 2001 Aug 04; 15(4):254-64. PubMed ID: 11810364 [Abstract] [Full Text] [Related]
14. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. Adams LL, Gatchel RJ, Robinson RC, Polatin P, Gajraj N, Deschner M, Noe C. J Pain Symptom Manage; 2004 May 04; 27(5):440-59. PubMed ID: 15120773 [Abstract] [Full Text] [Related]
15. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. Pain Med; 2008 May 04; 9(4):444-59. PubMed ID: 18489635 [Abstract] [Full Text] [Related]
17. Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP®-R), Current Opioid Misuse Measure (COMM)™, and provider gestalt. Varney SM, Perez CA, Araña AA, Carey KR, Ganem VJ, Zarzabal LA, Ramos RG, Bebarta VS. Intern Emerg Med; 2018 Dec 04; 13(8):1239-1247. PubMed ID: 29502329 [Abstract] [Full Text] [Related]
18. Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Morasco BJ, Dobscha SK. Gen Hosp Psychiatry; 2008 Dec 04; 30(2):93-9. PubMed ID: 18291290 [Abstract] [Full Text] [Related]
19. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. Pain Med; 2007 Dec 04; 8(7):573-84. PubMed ID: 17883742 [Abstract] [Full Text] [Related]
20. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors. Gupta A, Patton C, Diskina D, Cheatle M. Pain Physician; 2011 Dec 04; 14(4):383-9. PubMed ID: 21785482 [Abstract] [Full Text] [Related] Page: [Next] [New Search]